AI Science Tracker
EN

A Pathway-Driven Computational Drug Discovery Framework Integrating Machine Learning and Virtual Screening for Identification of Anti-Rheumatoid Arthritis Natural Small Molecules.

Affiliation not stated in the reviewed material · 19 Oct 2026 · medicine

Discovery

A Pathway-Driven Computational Drug Discovery Framework Integrating Machine Learning and Virtual Screening for Identification of Anti-Rheumatoid Arthritis Natural Small Molecules.

Source check: Source checked. Not independent scientific confirmation.

Finding: A pathway-guided ML workflow selects natural-molecule candidates for rheumatoid arthritis and tests prioritized compounds in an in-vitro inflammatory model after docking and molecular-dynamics analyses; the evidence supports those assay results, not therapeutic efficacy.

Technology: Pathway-guided machine learning ranks rheumatoid-arthritis target candidates and natural molecules; docking and molecular-dynamics analyses prioritize compounds for cellular testing.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Pathway-guided machine learning ranks rheumatoid-arthritis target candidates and natural molecules; docking and molecular-dynamics analyses prioritize compounds for cellular testing.
Test and result
Machine-learning ranking and virtual screening selected compounds; the paper reports reduced IL6/MMP3 in TNFα-stimulated MH7A cells after SM1 treatment. These in-vitro findings do not establish therapeutic efficacy.
Limitation / still unknown
Primary Methods/Results establish the cohort or experiment, comparison and stated validation limits.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://mdpi-res.com/d_attachment/pharmaceuticals/pharmaceuticals-19-01651/article_deploy/pharmaceuticals-19-01651.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.